Diquas Special Precautions

DIQUAS contains chlorhexidine. Chlorhexidine is known to induce hypersensitivity, including generalized allergic reactions and anaphylactic shock. The prevalence of chlorhedixine hypersensitivity is unknown, but available literature suggests this is likely to be very rare. DIQUAS should not be administered to anyone with a possible history of an allergic reaction to chlorhedixine.
If any signs or symptoms of a suspected hypersensitivity reaction such as itching, skin rash, redness, swelling, breathing difficulties, light headedness, and rapid heart rate develop, immediately stop using the product.
Appropriate therapeutic countermeasures must be instituted as clinically indicated.
Precautions concerning Use: Route of administration: Ophthalmic use only.
At the time of administration: Instruct the patient to be careful not to touch the tip of the bottle to the eye directly in order to avoid the contamination of the drug.
When more than one ophthalmic solution is used, at least 5 minutes of intervals should be taken.
Use in Children: The safety of this product to low birth weight infants, neonates, infants or children has not been established. (No clinical experience.)